Requirement for Daxx in mature T-cell proliferation and activation

Cell Death and Differentiation

Volumn 14, Issue 4, 2007, Pages 795-806

  Leal Sanchez, J ^a   Couzinet, A ^a   Rossin, A ^a   Abdel Sater, F ^a   Chakrabandhu, K ^a   Luci, C ^b   Anjuere, F ^b   Stebe, E ^a   Hancock, D ^c   Hueber, A O ^a  

^a CENTRE DE BIOCHIMIE   (France)

^b INSERM   (France)

^c THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAXX PROTEIN; FAS ANTIGEN; FAS LIGAND; LAT PROTEIN; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL MATURATION; CELL PROTECTION; CONTROLLED STUDY; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASPASES; CELL PROLIFERATION; FAS LIGAND PROTEIN; GENES, DOMINANT; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; T-LYMPHOCYTES;

MUS; MUS MUSCULUS;

EID: 33947375238     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402056     Document Type: Article

References (41)

1. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403-1408.
2. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10: 26-35.
3. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15: 2922-2933.
4. Yang X, Khosravi-Far R, Chang H, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997; 89: 1067-1076.
5. Torii S, Egan DA, Evans RA, Reed JC. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J 1999; 18: 6037-6049.
6. Chang HY, Yang X, Baltimore D. Dissecting Fas signaling with an altered-specificity death domain mutant: Requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation. Proc Natl Acad Sci USA 1999; 96: 1252-1256.
7. Chang HY, Nishitoh H, Yang X, Ichijo H, Baltimore D. Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 1998; 281: 1860-1863.
8. Ko YG, Kim EY, Kim T, Park H, Park HS, Choi EJ et al. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 2001; 276: 6030-6036.
9. Gostissa M, Morelli M, Mantovani F, Guida E, Piazza S, Collavin L et al. The transcriptional repressor hDaxx potentiates p53-dependent apoptosis. J Biol Chem 2004; 279: 48013-48023.
10. Villunger A, Huang DC, Holler N, Tschopp J, Strasser A. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD. J Immunol 2000; 165: 1337-1343.
11. Salomoni P, Khelifi AF. Daxx: Death or survival protein? Trends Cell Biol 2006; 16: 97-104.
12. Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, Degenhardt YY et al. Critical role for Daxx in regulating Mdm2. Nat Cell Biol 2006; 8: 855-862.
13. Zhao LY, Liu J, Sidhu GS, Niu Y, Liu Y, Wang R et al. Negative regulation of p53 functions by Daxx and the involvement of MDM2. J Biol Chem 2004; 279: 50566-50579.
14. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-795.
15. Beisner DR, Chu IH, Arechiga AF, Hedrick SM, Walsh CM. The requirements for Fas-associated death domain signaling in mature T cell activation and survival. J Immunol 2003; 171: 247-256.
16. Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH et al. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 2002; 22: 5419-5433.
17. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
18. Tai TS, Fang LW, Lai MZ. c-FLICE inhibitory protein expression inhibits T-cell activation. Cell Death Differ 2004; 11: 69-79.
19. Raoul C, Barthelemy C, Couzinet A, Hancock D, Pettmann B, Hueber AO. Expression of a dominant negative form of Daxx in vivo rescues motoneurons from Fas (CD95)-induced cell death. J Neurobiol 2005; 62: 178-188.
20. Michaelson JS, Bader D, Kuo F, Kozak C, Leder P. Loss of daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development. Genes Dev 1999; 13: 1918-1923.
21. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 1997; 27: 1207-1212.
22. Newton K, Harris AW, Bath ML, Smith KG, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998; 17: 706-718.
23. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. Immunity 1998; 8: 439-449.
24. U Zornig M, Hueber AO, Evan G. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic; mice. Curr Biol 1998; 8: 467-470.
25. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17-27.
26. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181: 71-77.
27. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-I/(Fas/CD95). Nature 1995; 373: 438-441.
28. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-448.
29. Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, Kappler J et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 2002; 16: 759-767.
30. Rathmell JC, Lindsten T, Zong WX, Cinalli RM. Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002; 3: 932-939.
31. Hao Z, Hampel B, Yagita H, Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med 2004; 199: 1355-1365.
32. Chen LY, Chen JD. Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol Cell Biol 2003; 23: 7108-7121.
33. Michaelson JS, Leder P. RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX. J Cell Sci 2003; 116: 345-352.
34. Cermak L, Simova S, Pintzas A, Horejsi V, Andera L. Molecular mechanisms involved in CD43-mediated apoptosis of TF-1 cells. Roles of transcription Daxx expression, and adhesion molecules. J Biol Chem 2002; 277: 7955-7961.
35. Wajant H, Ptizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003; 14: 53-66.
36. Budd RC, Yeh WC, Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 2006; 6: 196-204.
37. Thome M, Tschopp J. TCR-induced NF-kappaB activation: A crucial role for Carma1, Bcl10 and MALT1. Trends Immunol 2003; 24: 419-424.
38. Salomoni P, Guemah I, Pandolfi PP. The PML-nuclear body associated protein Daxx regulates the cellular response to CD40. Cell Death Differ 21306; 13: 672-675.
39. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 2001; 3: 708-714.
40. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24: 99-146.
41. Van Lint C, Ghysdael J, Paras Jr P, Burny A, Verdin E. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol 1994; 68: 2632-2648.